Deal of the Day — limited-time pharmacy picks!
Bevnexxa 400mg injection

Bevnexxa 400mg injection

Refrigerated 2–8°C · Online payment only

Salt Composition: Bevacizumab

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

16.0 ml in 1 vial

About The Product

Colone or Rectal, Chemotherapy Drug, Brain Tumor

Description

Bevnexxa 400mg injection is an anticancer medicine with Bevacizumab (400mg) as an active ingredient. It prescribes to treat certain types of cancer such as cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer.

It works by preventing the growth of new blood vessels that feed tumors and stops tumors from growing. It is an effective medicine and first-line of treatment when used in combination with other cancer medicines.

Uses

  • Cancer of colon and rectum
  • Ovarian cancer
  • Cervical cancer
  • Kidney cancer
  • Brain tumor
  • Non-small cell lung cancer

Side Effects

Bevnexxa 400mg injection may cause some side effects that vary from one patient to another. Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
Common side effects include:

  • Nosebleeds
  • Headache
  • High blood pressure
  • Inflammation of the nose
  • Protein in urine
  • Taste change
  • Dry skin
  • Hemorrhage
  • Increased lacrimation
  • Back pain
  • Exfoliative dermatitis

Contact the doctor immediately in case of any severe or unusual side effects.

How To Use

  • Bevnexxa 400mg is available in injection form and is advised to be taken as per the doctor's prescription. It can only be given intravenously by a doctor or nurse under strict medical supervision.Taking this injection in the wrong way may give you severe side effects.
  • In case of overdose, contact your healthcare provider or doctor and they will provide you with medical attention. Missing or overdosing will impact the overall health of the patients and may also have side effects. So, it is always advisable to follow the prescription of the doctor strictly.

How It Works

Bevnexxa 400mg injection is an anti-angiogenic medication with Bevacizumab as an active ingredient. It works by blocking a specific protein known as vascular endothelial growth factor (VEGF).

By blocking the action of specific protein it stops the formation of blood vessels that bring oxygen and nutrients to cancerous cells. Thereby, stop the growth & multiplication of cancer cells & slow down the progression of disease.

Safety Advice

Alcohol
Avoid the consumption of alcohol while taking Bevnexxa 400mg Injection, as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms.
Pregnancy
Do not take Bevnexxa 400mg Injection without consulting the doctor in case of pregnancy, as it can be unsafe to take it during this period.
Breast Feeding
Breastfeeding women should discuss the potential risks and benefits of the Bevnexxa 400mg Injection with their healthcare provider before starting treatment.
Driving
Bevnexxa 400mg Injection may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving.
Kidney
Bevnexxa 400mg Injection is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
Liver
Bevnexxa 400mg Injection is safe for use in liver disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.

FAQs

This is a chemotherapy based anticancer drug used to treat certain types of cancer such as cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer.

References

  • Emerson, M. V., Lauer, A. K., Flaxel, C. J., Wilson, D. J., Francis, P. J., Stout, J. T., ... & Klein, M. L. (2007). Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration. Retina, 27(4), 439-444. https://pubmed.ncbi.nlm.nih.gov/17420695/
  • Burger, R. A., Brady, M. F., Bookman, M. A., Fleming, G. F., Monk, B. J., Huang, H., ... & Liang, S. X. (2011). Incorporation of bevacizumab in the primary treatment of ovarian cancer. New England Journal of Medicine, 365(26), 2473-2483. https://ohiostate.elsevierpure.com/en/publications/incorporation-of-bevacizumab-in-the-primary-treatment-of-ovarian-/
  • Bergsland, E., & Dickler, M. N. (2004). Maximizing the potential of bevacizumab in cancer treatment. The Oncologist, 9(S1), 36-42. https://pubmed.ncbi.nlm.nih.gov/15178814/
  • Gil-Gil, M. J., Mesia, C., Rey, M., & Bruna, J. (2013). Bevacizumab for the treatment of glioblastoma. Clinical Medicine Insights: Oncology, 7, CMO-S8503. https://pmc.ncbi.nlm.nih.gov/articles/PMC3682734/
  • Falk, A. T., Barrière, J., François, E., & Follana, P. (2015). Bevacizumab: a dose review. Critical reviews in oncology/hematology, 94(3), 311-322. https://pubmed.ncbi.nlm.nih.gov/25703583/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026